NOS3 and metabolic syndrome: Mice lacking endothelial NO synthase (eNOS-/- mice) are hypertensive (9), but also develop symptoms of the Metabolic Syndrome (MetS) including glucose intolerance and dyslipidemia, alongside hyperleptinemia (10, 11) and defective mitochondrial β-oxidation and biogenesis (12, 13).